Our partner is focused on developing innovative treatments for neurological and psychiatric disorders, particularly epilepsy and other central nervous system conditions. Their goal is to address unmet medical needs by providing effective therapies that improve patient outcomes and quality of life.

This critical hire brought extensive experience in ADME and DMPK to program teams. They were responsible for comprehensive DMPK support, including design, execution, and interpretation of all DMPK studies, PK/PD modelling, collaboration with colleagues on translational studies of all discovery and development programs. They also helped write and review relevant sections of regulatory documents, as well as built and mentored a team.